Yahoo
OTC Markets OTCPK - Delayed Quote USD

Item 9 Labs Corp. (INLB)

0.0001 0.0000 (0.00%)
At close: October 30 at 5:00:00 PM EDT
Chart Range Bar
Loading chart for INLB
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0001
  • Volume 20,000
  • Avg. Volume 0
  • Market Cap (intraday) 10,236
  • Beta (5Y Monthly) 0.10
  • PE Ratio (TTM) --
  • EPS (TTM) -0.3300
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It operates through Cultivation, Franchising, and Corporate segments. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

www.item9labscorp.com

97

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

INLB
0.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

INLB
0.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

INLB
98.46%
S&P 500 (^GSPC)
81.91%

5-Year Return

INLB
99.99%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY23
Revenue 5M
Earnings -3.26M
Profit Margin -65.10%

Q2

FY22

Q3

FY22

Q4

FY22

Q1

FY23

-15M
-10M
-5M
0
5M
-400.0%
-300.0%
-200.0%
-100.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -157.61%

  • Return on Assets (ttm)

    -5.40%

  • Return on Equity (ttm)

    -47.35%

  • Revenue (ttm)

    19.69M

  • Net Income Avi to Common (ttm)

    -31.03M

  • Diluted EPS (ttm)

    -0.3300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    183.43k

  • Total Debt/Equity (mrq)

    65.14%

  • Levered Free Cash Flow (ttm)

    9.99M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: